Balchem boosted by microencapuslation trend

By Clarisse Douaud

- Last updated on GMT

Related tags Percent Nutrition

Profits are up at Balchem Corporation following the announcement of
its results for the quarter ended September 30, 2006, and the group
reported nutritional products formed an important part of this
growth.

The New York-based microencapsulation company reported net earnings for the third quarter were $3.2mn, a 4.2 percent increase over the prior year comparable period. Earnings from operations were up 5.3 percent - from $4.7mn in 2005 Q3, to $5.0mn in 2006 Q3.

Microencapsulation has gained in popularity with food companies and is especially useful for the delivery of sensitive nutrients via nutraceuticals and functional foods.

The latest results from Balchem indicate the company has benefited from the opportunities presented by the nutrition industry in particular.

Frost & Sullivan reported last year demand for encapsulation technologies is estimated to be growing at 10 percent, driven both by increasing fortification with health ingredients and consumer demand for novel products.

But at Balchem, sales for the encapsulated/nutritional products segment were $10.3mn for Q3 - up 21.7 percent from the prior year comparable quarter. This includes $1.2mn in sales from its Chelated Minerals Corporation acquisition.

In particular Balchem said that its food, nutritional and human choline products were performing well, with nine percent over the prior year period.

Earnings from operations in the encapsulation/nutrition segment improved 8.7 percent third quarter to third quarter, reaching $1.0mn in the current period.

Microcapsules are tiny particles that contain an active agent or core material surrounded by a shell or coating, and are now increasingly being used in food ingredients preparation.

The technology can be used to deliver a host of ingredients - flavors, oils, peptides, amino acids, enzymes, acidulants, colours and sweeteners - in a range of food formulations. It can also decrease costs for food makers, particularly those using sensitive ingredients such as probiotics.

The company's overall sales for Q3 from all three of its divisions were $25.1m in Q3, up 18.8 percent from the comparable quarter last year which hit $21.1m.

Related topics Dosage forms & delivery formats

Related products

show more

The Art of Organic Certification

The Art of Organic Certification

Content provided by FoodChain ID | 09-Oct-2023 | White Paper

The organic food market has experienced remarkable growth over the past decade, providing a major opportunity for food brands and manufacturers to tap...

Discover how to enhance ingredient functionality

Discover how to enhance ingredient functionality

Content provided by Lonza | 04-Oct-2023 | Product Brochure

Consumer demand for capsules shows no sign of slowing down—they are the globally preferred dosage form for 50% of consumers. But in an increasingly saturated...

Related suppliers

Follow us

Products

View more

Webinars